mesalamine has been researched along with Celiac Disease in 10 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Celiac Disease: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this study is to evaluate the safety and efficacy of Small intestinal release mesalamine (SIRM) for symptom relief in refractory celiac disease (RCD)." | 7.77 | Small intestinal release mesalamine for the treatment of refractory celiac disease type I. ( Dennis, M; Jamma, S; Kelly, CP; Leffler, DA; Najarian, RM; Schuppan, DB; Sheth, S, 2011) |
| "The goal of this study is to evaluate the safety and efficacy of Small intestinal release mesalamine (SIRM) for symptom relief in refractory celiac disease (RCD)." | 3.77 | Small intestinal release mesalamine for the treatment of refractory celiac disease type I. ( Dennis, M; Jamma, S; Kelly, CP; Leffler, DA; Najarian, RM; Schuppan, DB; Sheth, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, E | 1 |
| Viscido, A | 1 |
| Castelli, V | 1 |
| Maggiani, C | 1 |
| d'Angelo, M | 1 |
| Di Giacomo, E | 1 |
| Antonosante, A | 1 |
| Picarelli, A | 1 |
| Frieri, G | 1 |
| Bar Yehuda, S | 1 |
| Axlerod, R | 1 |
| Toker, O | 1 |
| Zigman, N | 1 |
| Goren, I | 1 |
| Mourad, V | 1 |
| Lederman, N | 1 |
| Cohen, N | 1 |
| Matz, E | 1 |
| Dushnitzky, D | 1 |
| Gavish, M | 1 |
| Borovsky, N | 1 |
| Schwarts, D | 1 |
| Dotan, I | 1 |
| Turner, D | 1 |
| Krums, LM | 1 |
| Babaian, AF | 1 |
| Bykova, SV | 1 |
| Lishchinskaia, AA | 1 |
| Khomeriki, SG | 1 |
| Gudkova, RB | 1 |
| Sabel'nikova, EA | 1 |
| Kniazev, OV | 1 |
| Parfenov, AI | 1 |
| Sitkin, SI | 1 |
| Tkachenko, EI | 1 |
| Vakhitov, TIa | 1 |
| Oreshko, LS | 1 |
| Zhigalova, TN | 1 |
| Rowinski, SA | 1 |
| Christensen, E | 1 |
| Jamma, S | 1 |
| Leffler, DA | 1 |
| Dennis, M | 1 |
| Najarian, RM | 1 |
| Schuppan, DB | 1 |
| Sheth, S | 1 |
| Kelly, CP | 1 |
| Green, PH | 1 |
| Lebwohl, B | 1 |
| Cheng, SX | 1 |
| Raizner, A | 1 |
| Phatak, UP | 1 |
| Cho, JH | 1 |
| Pashankar, DS | 1 |
| Trujillo, L | 1 |
| Reyes, J | 1 |
| de la Sant, E | 1 |
| Márquez, L | 1 |
| O'Mahony, S | 1 |
| Nawroz, IM | 1 |
| Ferguson, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Diagnostic Role of Enteroscopy in Small Intestinal Diseases at Al-Rajhi University Hospital[NCT05470946] | 50 participants (Anticipated) | Interventional | 2022-08-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for mesalamine and Celiac Disease
| Article | Year |
|---|---|
Epidemiologic and therapeutic aspects of refractory coeliac disease - a systematic review.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Celiac Disease; Cla | 2016 |
1 trial available for mesalamine and Celiac Disease
| Article | Year |
|---|---|
[Serum metabolome by gas chromatography-mass spectrometry (GC-MS) in patients with ulcerative colitis and celiac disease].
Topics: Adolescent; Adult; Carboxylic Acids; Celiac Disease; Colitis, Ulcerative; Combined Modality Therapy; | 2013 |
8 other studies available for mesalamine and Celiac Disease
| Article | Year |
|---|---|
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet.
Topics: Aldehydes; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Case-Control Studies; Catalase; Ce | 2018 |
The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biological Products; Case | 2019 |
Celiac disease associated with ulcerative colitis.
Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Celiac Disease; Colit | 2019 |
Small intestinal release mesalamine for the treatment of refractory celiac disease type I.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Celiac Disease; | 2011 |
Mesalamine for refractory celiac disease: an old medicine for a new disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celiac Disease; Drug Design; Humans; Mesalamine; Treatment | 2011 |
Celiac disease in a child with ulcerative colitis: a possible genetic association.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celiac Disease; Child; Colitis, Ulcerative; Diet, Gluten-Fr | 2013 |
[Lymphocitic colitis and celiac disease].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celiac Disease; Colitis; Female; Humans; Mesalamine | 2006 |
Coeliac disease and collagenous colitis.
Topics: Adult; Aminosalicylic Acids; Celiac Disease; Colitis; Diarrhea; Humans; Jejunum; Male; Mesalamine; R | 1990 |